|
English
|
正體中文
|
简体中文
|
總筆數 :2856565
|
|
造訪人次 :
53381782
線上人數 :
1248
教育部委託研究計畫 計畫執行:國立臺灣大學圖書館
|
|
|
顯示項目 327401-327410 / 2348971 (共234898頁)
<< < 32736 32737 32738 32739 32740 32741 32742 32743 32744 32745 > >>
每頁顯示[10|25|50]項目
| 國立臺灣大學 |
2015 |
Diabetes mellitus with poor glycemic control increases bladder cancer recurrence risk in patients with upper urinary tract urothelial carcinoma
|
Tai, Yi-Sheng; Chen, Chung-Hsin; Huang, Chao-Yuan; Tai, Huai-Chin; Wang, Sho-Mon; Pu, Yeong-Shiau; 戴槐青; 蒲永孝; 陳忠信; 黃昭淵; 王碩盟 |
| 臺大學術典藏 |
2021-10-14T02:45:49Z |
Diabetes mellitus with poor glycemic control increases bladder cancer recurrence risk in patients with upper urinary tract urothelial carcinoma
|
Tai Y.-S.; Chen C.-H.; CHAO-YUAN HUANG; Tai H.-C.; Wang S.-M.; Pu Y.-S. |
| 臺大學術典藏 |
2021-01-26T03:36:50Z |
Diabetes mellitus with poor glycemic control increases bladder cancer recurrence risk in patients with upper urinary tract urothelial carcinoma
|
Tai Y.-S.;Chung-Hsin Chen;Huang C.-Y.;Tai H.-C.;Wang S.-M.;Pu Y.-S.; Tai Y.-S.; CHUNG-HSIN CHEN; Huang C.-Y.; Tai H.-C.; Wang S.-M.; Pu Y.-S. |
| 臺大學術典藏 |
2021-02-02T00:46:19Z |
Diabetes mellitus with poor glycemic control increases bladder cancer recurrence risk in patients with upper urinary tract urothelial carcinoma
|
Tai Y.-S.;Chen C.-H.;Huang C.-Y.;Tai H.-C.;Wang S.-M.;Yeong-Shiau Pu; Tai Y.-S.; Chen C.-H.; Huang C.-Y.; Tai H.-C.; Wang S.-M.; YEONG-SHIAU PU |
| 國立臺灣大學 |
2008 |
DIABETES MELLITUS, CHRONIC HEPATITIS C, AND HEPATOCELLULAR CARCINOMA - REPLY
|
陳秀熙; 邱月暇 |
| 中國醫藥大學 |
2004 |
Diabetes Mellitus, Hyperhomocystinemia and Atherosclerotic Vascular Disease in Taiwanese Chronic Hemodialysis Patients: A Retrospective Study
|
李志雄(Chil-Hsiung Lee); 張學文(Hsueh-Wen Chang); 王怡寬(I-Kuan Wang); 林俊良(Chun-Liang Lin); 陳德全(Te-Chuan Chen); 王寶惠(Pao-Hui Wang); 張弘育(Hung-Yu Chang); 陳靖博(Jin-Bor Chen); 許國泰(Kuo-Tai Hsu); 莊峰榮(Feng-Rong Chuang)* |
| 臺大學術典藏 |
2018-09-10T18:07:13Z |
Diabetes mellitus, superoxide dismutase and peroxisome proliferator activated receptor gamma polymorphisms modify the outcome of end-stage renal disease patients of Han Chinese origin
|
Chao, C.-T. and Huang, J.-W. and Chiang, C.-K. and Chen, Y.-C. and Fang, C.-C. and Hu, F.-C. and Chang, C.-C. and Yen, C.-J.; CHENG-CHUNG FANG; CHIH-KANG CHIANG|CHUNG-JEN YEN; CHIA-TER CHAO; JENQ-WEN HUANG |
| 臺大學術典藏 |
2021-05-27T09:06:32Z |
Diabetes mellitus, superoxide dismutase and peroxisome proliferator activated receptor gamma polymorphisms modify the outcome of end-stage renal disease patients of Han Chinese origin
|
Chao C.-T.; Huang J.-W.; CHIH-KANG CHIANG; Chen Y.-C.; Fang C.-C.; Hu F.-C.; Chang C.-C.; Yen C.-J. |
| 臺大學術典藏 |
2021-08-20T08:19:38Z |
Diabetes mellitus, superoxide dismutase and peroxisome proliferator activated receptor gamma polymorphisms modify the outcome of end-stage renal disease patients of Han Chinese origin
|
CHIA-TER CHAO; Huang J.-W.; Chiang C.-K.; Chen Y.-C.; Fang C.-C.; Hu F.-C.; Chang C.-C.; Yen C.-J. |
| 臺大學術典藏 |
2022-05-09T08:46:30Z |
Diabetes mellitus, superoxide dismutase and peroxisome proliferator activated receptor gamma polymorphisms modify the outcome of end-stage renal disease patients of Han Chinese origin
|
Chao C.-T.; Huang J.-W.; Chiang C.-K.; YEN-CHING CHEN; Fang C.-C.; Hu F.-C.; Chang C.-C.; Yen C.-J. |
顯示項目 327401-327410 / 2348971 (共234898頁)
<< < 32736 32737 32738 32739 32740 32741 32742 32743 32744 32745 > >>
每頁顯示[10|25|50]項目
|
